HTA18 Impact of The Use of Cost-Effectiveness Analysis (CEA) on Patient Access to Medicines: A Comparison of CEA vs Non-CEA Markets
| Autor: | Katsikostas-Michopoulos, G, Alleman, C, Azough, A, Hickson, S, Griffin, A, Rollmann, D, Mckendrick, J |
|---|---|
| Zdroj: | In Value in Health December 2022 25(12) Supplement:S299-S299 |
| Databáze: | ScienceDirect |
| Externí odkaz: |
|
Full Text from ScienceDirect